TY - JOUR
T1 - Translation and validation of the Cancer-Related Fatigue Scale in Greek in a sample of patients with advanced prostate cancer
AU - Charalambous, Andreas
AU - Kaite, Charis
AU - Constantinou, Marianna
AU - Kouta, Christiana
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Objective: To translate and validate the Cancer- Related Fatigue (CRF) Scale in the Greek language. Design: A cross-sectional descriptive design was used in order to translate and validate the CRF Scale in Greek. Factor analyses were performed to understand the psychometric properties of the scale and to establish construct, criterion and convergent validity. Setting: Outpatients' oncology clinics of two public hospitals in Cyprus. Participants: 148 patients with advanced prostate cancer undergoing chemotherapy. Results: The Cancer Fatigue Scale (CFS) had good stability (test-retest reliability r=0.79, p<0.001) and good internal consistency (Cronbach's α coefficient for all 15 items α=0.916). Furthermore, the Kaiser-Meyer- Olkin Measure of Sampling Adequacy (KMO value) was found to be 0.743 and considered to be satisfactory (>0.5). The correlations between the CFS physical scale (CFS-FS scale) and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 physical subscales were found to be significant (r=-0.715). The same occurred between CFS cognitive and EORTC cognitive subscale (r=-0.579). Overall, the criterion validity was verified. The same occurs for the convergent validity of the CFS since all correlations with the Global Health Status (q29-q30) were found to be significant. Conclusions: This is the first validation study of the CRF Scale in Greek and warrant of its use in the assessment of prostate cancer patient's related fatigue. However, further testing and validation is needed in the early stages of the disease and in patients in later chemotherapy cycles.
AB - Objective: To translate and validate the Cancer- Related Fatigue (CRF) Scale in the Greek language. Design: A cross-sectional descriptive design was used in order to translate and validate the CRF Scale in Greek. Factor analyses were performed to understand the psychometric properties of the scale and to establish construct, criterion and convergent validity. Setting: Outpatients' oncology clinics of two public hospitals in Cyprus. Participants: 148 patients with advanced prostate cancer undergoing chemotherapy. Results: The Cancer Fatigue Scale (CFS) had good stability (test-retest reliability r=0.79, p<0.001) and good internal consistency (Cronbach's α coefficient for all 15 items α=0.916). Furthermore, the Kaiser-Meyer- Olkin Measure of Sampling Adequacy (KMO value) was found to be 0.743 and considered to be satisfactory (>0.5). The correlations between the CFS physical scale (CFS-FS scale) and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 physical subscales were found to be significant (r=-0.715). The same occurred between CFS cognitive and EORTC cognitive subscale (r=-0.579). Overall, the criterion validity was verified. The same occurs for the convergent validity of the CFS since all correlations with the Global Health Status (q29-q30) were found to be significant. Conclusions: This is the first validation study of the CRF Scale in Greek and warrant of its use in the assessment of prostate cancer patient's related fatigue. However, further testing and validation is needed in the early stages of the disease and in patients in later chemotherapy cycles.
UR - http://www.scopus.com/inward/record.url?scp=85002157993&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2016-011798
DO - 10.1136/bmjopen-2016-011798
M3 - Article
AN - SCOPUS:85002157993
SN - 2044-6055
VL - 6
JO - BMJ Open
JF - BMJ Open
IS - 12
M1 - e011798
ER -